• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by CareMax Inc. (Amendment)

    2/9/22 9:11:44 AM ET
    $CMAX
    Hospital/Nursing Management
    Health Care
    Get the next $CMAX alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No. 2 CAREMAX INC CLASS A COMMON STOCK Cusip #14171W103 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #14171W103 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 156,863 Item 6: 0 Item 7: 3,937,119 Item 8: 0 Item 9: 3,937,119 Item 11: 4.521% Item 12: HC Cusip #14171W103 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 3,937,119 Item 8: 0 Item 9: 3,937,119 Item 11: 4.521% Item 12: IN Item 1(a). Name of Issuer: CAREMAX INC Item 1(b). Address of Issuer's Principal Executive Offices: 1000 NW 57 COURT, SUITE 400 MIAMI, FL 33126 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: CLASS A COMMON STOCK Item 2(e). CUSIP Number: 14171W103 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 3,937,119 (b) Percent of Class: 4.521% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 156,863 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 3,937,119 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof, the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following (X). Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of CAREMAX INC. No one other person's interest in the CLASS A COMMON STOCK of CAREMAX INC is more than five percent of the total outstanding CLASS A COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 8, 2022 Date /s/ Kevin M. Meagher Signature Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Management & Research Company LLC IA Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act ("Fidelity Funds") advised by Fidelity Management & Research Company LLC ("FMR Co. LLC"), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds' Boards of Trustees. FMR Co. LLC carries out the voting of the shares under written guidelines established by the Fidelity Funds' Boards of Trustees. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 8, 2022, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the CLASS A COMMON STOCK of CAREMAX INC at December 31, 2021. FMR LLC By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 30, 2018, by and on behalf of Abigail P. Johnson* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414.
    Get the next $CMAX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CMAX

    DatePrice TargetRatingAnalyst
    2/26/2024$1.50 → $7.50Buy → Hold
    Jefferies
    11/17/2023$5.00 → $1.00Buy → Neutral
    UBS
    11/10/2023$3.00 → $2.00Overweight → Neutral
    Piper Sandler
    3/17/2023$7.00 → $4.00Outperform → Market Perform
    TD Cowen
    9/7/2022$7.50Hold
    Truist
    1/7/2022$14.00Buy
    UBS
    10/20/2021$15.00Buy
    Jefferies
    9/13/2021$14.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CMAX
    Leadership Updates

    Live Leadership Updates

    See more
    • Steward Health Care Appoints Rubén José King-Shaw Jr to Its Board of Directors

      Steward Health Care, the nation's largest physician-led health care network, today announced the appointment of Rubén José King-Shaw Jr to its Board of Directors. King-Shaw currently serves as Steward's Executive Vice President & Chief Strategy Officer, where he has led a number of critical strategic acquisitions and divestitures including the sale of Steward Health Choice Arizona and the significant merger of Steward's value-based Medicare business with Caremax (NASDAQ:CMAX). King-Shaw also chairs Steward's offshore captive insurance company, TRACO, which is domiciled in Panamá. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220

      7/7/22 5:12:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax, Inc. Announces Board Leadership Transition

      CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced the appointment of Mr. Jose R. Rodriguez as Chair of CareMax's board of directors, to succeed Mr. Richard A. Barasch, who has resigned from the Board. Mr. Rodriguez has served as a member of CareMax's board of directors since June 2021 and previously served as CareMax's Lead Independent Director. Mr. Barasch will continue to serve as an advisor to CareMax's board of directors. "We are excited that Jose has agreed to lead CareMax's board of directors as we start our first full year as a public company. The board and I believe Jose's recognized leadership in

      2/7/22 4:30:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax, Inc. Appoints Beatriz Assapimonwait to Board of Directors

      CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading technology-enabled provider of value-based care to seniors, today announced that Beatriz Assapimonwait has been appointed as an independent member of the CareMax board of directors. Ms. Assapimonwait brings to CareMax 38 years of Medicare managed care experience, including a decade of experience as a leader in the Medicare markets in South Florida, North Florida, and Puerto Rico. Most recently, Ms. Assapimonwait served as the Regional President for Humana South Florida where she was responsible for developing market strategies and leading market operations. Before that, Ms. Assapimonwait was CEO of Family Physicians of Winter Park

      9/20/21 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    SEC Filings

    See more
    • CareMax Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - CareMax, Inc. (0001813914) (Filer)

      11/25/24 6:35:08 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update, Financial Statements and Exhibits

      8-K - CareMax, Inc. (0001813914) (Filer)

      11/18/24 6:55:10 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form NT 10-Q filed by CareMax Inc.

      NT 10-Q - CareMax, Inc. (0001813914) (Filer)

      11/13/24 4:56:07 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CareMax Enters Into Agreement to Sell Core Centers' Assets

      ClareMedica Health Partners to become "Stalking Horse" Bidder to Acquire CareMax's Core Centers' Assets CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced that it has entered into a "stalking horse" purchase agreement with ClareMedica Health Partners ("ClareMedica"), a leader in value-based primary care serving patients in Florida, pursuant to which ClareMedica will acquire CareMax's core centers' assets including a vast majority of CareMax's operating clinics (the "Core Centers' Assets"). The transaction will be implemented pursuant to a previously announced prearranged chapter 11 plan support

      11/25/24 6:30:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reaches Agreements to Sell Management Services Organization and Core Centers' Assets

      Revere Medical Enters into Agreement to Acquire CareMax's Management Services Organization Agreement in Principle Reached with "Stalking Horse" for Core Centers' Assets Sale Transactions to be Implemented Through an Expedited Prearranged Chapter 11 Plan Supported by 100% of CareMax's Secured Lenders CareMax Secures $30.5 Million in Debtor in Possession Financing to Support Operations and Continuing Provision of Healthcare Services Throughout Restructuring Process CareMax, Inc. (NASDAQ:CMAX, CMAXW)) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced it has entered into an agreement to sell its management services organization

      11/17/24 6:17:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reports Second Quarter 2024 Results

      Second Quarter Medicare Advantage Membership of 104,000, up 1% year-over-year Second Quarter Total Revenue of $198.6 million, down 12% year-over-year CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2024. "Although our medical expense ratio continued to run higher than target levels, we were able to manage toward another quarter of sequential improvement in MER in the second quarter, and we continued to make progress against our clinical initiatives," said Carlos de Solo, Chief Executive Officer. Mr. de Solo continued, "Additiona

      8/9/24 5:30:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by CareMax Inc. (Amendment)

      SC 13G/A - CareMax, Inc. (0001813914) (Subject)

      2/14/24 7:36:14 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by CareMax Inc.

      SC 13G - CareMax, Inc. (0001813914) (Subject)

      2/12/24 10:53:22 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13D/A filed by CareMax Inc. (Amendment)

      SC 13D/A - CareMax, Inc. (0001813914) (Subject)

      3/13/23 5:06:40 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Borkowski Edward

      3 - CareMax, Inc. (0001813914) (Issuer)

      10/2/24 5:03:58 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • SEC Form 3 filed by new insider Rundell Paul Brent

      3 - CareMax, Inc. (0001813914) (Issuer)

      6/20/24 4:18:15 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • Flynn James E converted options into 12,123 shares (SEC Form 4)

      4 - CareMax, Inc. (0001813914) (Issuer)

      11/21/23 6:09:00 PM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • CareMax downgraded by Jefferies with a new price target

      Jefferies downgraded CareMax from Buy to Hold and set a new price target of $7.50 from $1.50 previously

      2/26/24 7:26:58 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax downgraded by UBS with a new price target

      UBS downgraded CareMax from Buy to Neutral and set a new price target of $1.00 from $5.00 previously

      11/17/23 7:26:57 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded CareMax from Overweight to Neutral and set a new price target of $2.00 from $3.00 previously

      11/10/23 7:33:59 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care

    $CMAX
    Financials

    Live finance-specific insights

    See more
    • CareMax Reports Fourth Quarter and Full Year 2023 Results

      Met 2023 Guidance for Medicare Advantage Membership and Total Revenue Year-end 2023 Medicare Advantage Membership of 111,500, up 19% year-over-year Full Year 2023 Total Revenue of $751.1 million, up 19% year-over-year Exploring Strategic Options to Maximize Value of Certain Assets and Generate Further Liquidity CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023. "In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business," said Carlos de Solo, C

      3/18/24 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Reports Third Quarter 2023 Results

      Third Quarter Medicare Advantage Membership of 107,000, up 171% year-over-year Third Quarter Total Revenue of $201.8 million, up 28% year-over-year Reaffirming Full Year 2023 Revenue Guidance; Updating Full Year 2023 Medicare Advantage Membership and Adjusted EBITDA Guidance CareMax, Inc. (NASDAQ:CMAX, CMAXW))) ("CareMax" or the "Company"), a leading technology-enabled value-based care delivery system, today announced financial results for the third quarter ended September 30, 2023. "Tomorrow marks one year since the acquisition of our national MSO and nearly two and a half years of rapid growth in our patient and provider base. Over that period, we experienced fluctuations in o

      11/9/23 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care
    • CareMax Schedules Third Quarter 2023 Earnings Conference Call

      CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW))), a leading value-based care delivery system, announced today that it will release its financial results for the third quarter 2023 before the opening of the financial markets on Thursday, November 9, 2023, and host a conference call at 8:30 am Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (888) 330-2508 for U.S. participants, or (240) 789-2735 for international participants, and referencing conference ID 7874605. A live audio webcast and replay of the event will also be available on the "Events & Presentations" section of CareMax's investor relations website at ir.caremax.com. About CareM

      10/25/23 6:55:00 AM ET
      $CMAX
      Hospital/Nursing Management
      Health Care